Physician

Heather Yeckes-Rodin, M.D.

According to 2025 Medicare claims, Heather Yeckes-Rodin, M.D. (NPI: 1740214840) practices medical oncology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from St. Lucie, FL. This provider's primary affiliated billing organization is HEM ONC ASSOCIATES OF THE TREASURE COAST, PA (NPI: 1205882867; TIN: 650696665) and primary practice location at 34996-3349.

Yeckes-Rodin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,075 traditional Medicare patients, billed 229,887 HCPCS/CPT codes, and received $4,018,402 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 4,827 prescription claims across 787 beneficiaries totaling $6,969,828 in drug costs, led by Ibrance (Palbociclib). DME data shows 48 claims. Open Payments data shows 207 records totaling $30,743. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,697,805 to $4,018,402. Similarly, Part D prescription costs have risen steadily, from $2,341,873 to $6,969,828. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,553 and ending at $2,890.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,375	341,509	$2,697,805
2016	1,446	384,528	$3,549,431
2017	1,438	389,766	$3,835,342
2018	1,367	326,773	$3,848,180
2019	1,373	371,365	$4,851,624
2020	1,314	405,821	$5,240,665
2021	1,263	374,783	$5,321,342
2022	1,193	319,119	$5,056,048
2023	1,112	230,056	$4,248,214
2024	1,075	229,887	$4,018,402

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	404	2,978	$2,341,873
2016	452	3,303	$2,575,759
2017	495	3,910	$3,231,033
2018	559	3,974	$3,111,720
2019	626	4,451	$3,845,952
2020	691	4,577	$4,232,425
2021	744	4,868	$4,189,102
2022	751	4,468	$4,767,747
2023	778	4,597	$5,381,009
2024	787	4,827	$6,969,828

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	167	$49,888
2016	24	109	$13,798
2017	N/R	71	$11,616
2018	N/R	73	$6,445
2019	N/R	79	$7,028
2020	N/R	44	$3,082
2021	N/R	66	$3,610
2022	N/R	65	$1,592
2023	N/R	24	$4,323
2024	N/R	48	$2,246

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	516	1,771	$70
82378	Carcinoembryonic antigen (cea) protein level	372	723	$19
80053	Blood test, comprehensive group of blood chemicals	706	2,144	$10
36415	Insertion of needle into vein for collection of blood sample	710	1,653	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	784	2,600	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	137	3,822	$2,178,904
Calquence	Acalabrutinib Maleate	52	1,560	$746,985
Verzenio	Abemaciclib	42	1,176	$555,678
Zejula	Niraparib Tosylate	19	570	$327,314
Imbruvica	Ibrutinib	29	862	$323,097

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$891
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	13	$510
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$426
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$419

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	206	$5,343	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$25,400	AstraZeneca UK Limited
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Heather Yeckes-Rodin, M.D.?

Tedicare shows public-source Medicare data for Heather Yeckes-Rodin, M.D. (NPI 1740214840), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Heather Yeckes-Rodin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Heather Yeckes-Rodin, M.D.?

Heather Yeckes-Rodin, M.D. is linked to HEM ONC ASSOCIATES OF THE TREASURE COAST, PA (billing NPI 1205882867) in the available physician profile data.

Does Heather Yeckes-Rodin, M.D. have Open Payments data?

Heather Yeckes-Rodin, M.D. has 207 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.